Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
immunicell (1 trial)
tcb008 (1 trial)
allogeneic gamma-delta t cells (1 trial)
Carcinoma, Renal Cell (Phase 3)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Melanoma (Phase 3)
Trials (3 total)
Trial APIs (3 total)